Back
Spyre Therapeutics Vs. iBio Industry Stock Comparison
Sell
27
SYRE
Spyre Therapeutics
Last Price:
22.90
Seasonality Move:
49.76%
Sell
18
IBIO
iBio
Last Price:
2.17
Seasonality Move:
12.61%
Sell
27
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $22.90. The Score for SYRE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
iBio (IBIO)
is a Sell
Is iBio a Buy, Sell or Hold?
- The current iBio [IBIO] share price is $2.09. The Score for IBIO is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- IBIO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $22.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
IBIO Stock Price Chart
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.94 | Sell |
| Relative Strength Index (14 RSI): | 28.27 | Sell |
| Chaikin Money Flow: | -408420 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.66 - 36.8) | Sell |
| Bollinger Bands (100): | (27.1 - 39.22) | Sell |
IBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 41.75 | Sell |
| Chaikin Money Flow: | -11105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.19 - 2.49) | Sell |
| Bollinger Bands (100): | (1.2 - 2.42) | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.49 | Sell |
| 20-day SMA: | 31.58 | Sell |
| 50-day SMA: | 33.73 | Sell |
| 200-day SMA: | 24.46 | Sell |
| 8-day EMA: | 26.49 | Sell |
| 20-day EMA: | 30.15 | Sell |
| 50-day EMA: | 32.53 | Sell |
| 200-day EMA: | 27.05 | Sell |
IBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.27 | Sell |
| 20-day SMA: | 2.36 | Sell |
| 50-day SMA: | 2.1 | Sell |
| 200-day SMA: | 2.91 | Sell |
| 8-day EMA: | 2.21 | Sell |
| 20-day EMA: | 2.27 | Sell |
| 50-day EMA: | 2.15 | Sell |
| 200-day EMA: | 6.89 | Sell |
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
iBio Earnings Growth & IBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $6.77 per share, a decrease next quarter of $0.00 per share, an increase this year of $100.79 per share, and an increase next year of $9.08 per share.
Spyre Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
iBio Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||